Metabolic Adaptations to Weight Loss With and Without Exercise (WAX)
Obesity, Metabolic Disease, Metabolic Syndrome
About this trial
This is an interventional basic science trial for Obesity
Eligibility Criteria
Inclusion criteria Age: 18-40 Body Mass Index: 30-40 kg/m2 Weight stable (±3kg for greater than or equal to about 2 months) No regularly planned exercise/physical activity Women must have regularly occurring menses and must be premenopausal Exclusion criteria EKG abnormalities Evidence/history of cardiovascular disease, diabetes or other metabolic disease Medications known to affect lipid or glucose metabolism Pregnant or lactating Tobacco or e-cigarette use Prior experience of hypersensitivity to insulin, human albumin, and potassium chloride injection. Allergies/hypersensitivity to local anesthetics of the amide type (e.g., lidocaine) History of hyperkalemia or potential for developing hyperkalemia (including but not limited to taking drugs that may induce hyperkalemia such as cardiac glycosides or potassium sparing diuretics) Anti-coagulant medication (e.g., Coumadin, Rivaroxaban) and Lidocaine allergy/sensitivity are exclusion criteria for the biopsy procedure.
Sites / Locations
- University of MichiganRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Moderate Intensity Continuous Training (MICT) exercise group
No exercise (Control)
45 minutes of continuous steady-state exercise at 70% maximal heart rate throughout the 10% weight loss phase of the study
to remain sedentary (no planned physical exercise) throughout the duration of the 10% weight loss phase of the study